PH16762A - Ubedecabenone compositions having enhanced absorption properties - Google Patents

Ubedecabenone compositions having enhanced absorption properties

Info

Publication number
PH16762A
PH16762A PH24335A PH24335A PH16762A PH 16762 A PH16762 A PH 16762A PH 24335 A PH24335 A PH 24335A PH 24335 A PH24335 A PH 24335A PH 16762 A PH16762 A PH 16762A
Authority
PH
Philippines
Prior art keywords
ubedecabenone
compositions
absorption properties
enhanced absorption
enhanced
Prior art date
Application number
PH24335A
Other languages
English (en)
Inventor
Kzuo Taki
Hideo Takahira
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of PH16762A publication Critical patent/PH16762A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PH24335A 1979-07-25 1980-07-25 Ubedecabenone compositions having enhanced absorption properties PH16762A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9363679A JPS5618914A (en) 1979-07-25 1979-07-25 Ubidecarenone composition having good absorbability

Publications (1)

Publication Number Publication Date
PH16762A true PH16762A (en) 1984-02-15

Family

ID=14087821

Family Applications (1)

Application Number Title Priority Date Filing Date
PH24335A PH16762A (en) 1979-07-25 1980-07-25 Ubedecabenone compositions having enhanced absorption properties

Country Status (7)

Country Link
US (1) US4325942A (es)
EP (1) EP0023349B1 (es)
JP (1) JPS5618914A (es)
CA (1) CA1159767A (es)
DE (1) DE3070508D1 (es)
ES (1) ES493679A0 (es)
PH (1) PH16762A (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58113127A (ja) * 1981-12-28 1983-07-05 Ajinomoto Co Inc ユビデカレノン含有水性液
IT1157269B (it) * 1982-03-19 1987-02-11 Seuref Ag Nuove formulazioni farmaceutiche contenenti il coenzima q10 adatte per la somministrazione topica
JPS5913710A (ja) * 1982-07-15 1984-01-24 Shiseido Co Ltd 養毛料
EP0104043A3 (en) * 1982-09-20 1984-06-06 Ajinomoto Co., Inc. Foodstuffs and pharmaceuticals
IT1191608B (it) * 1985-02-01 1988-03-23 Zambon Spa Composizione farmaceutica e forme farmaceutiche che la contengono
JPS61221131A (ja) * 1985-03-28 1986-10-01 Eisai Co Ltd 吸収促進したユビデカレノン含有組成物
US4874795A (en) * 1985-04-02 1989-10-17 Yesair David W Composition for delivery of orally administered drugs and other substances
IE59067B1 (en) * 1985-04-02 1993-12-15 Yesair David W Composition for delivery of orally administered drugs and other substances
US4824669A (en) * 1985-04-11 1989-04-25 Board Of Regents, The University Of Texas System Formulations of coenzyme Q10 for intravenous use
JPH0629180B2 (ja) * 1986-06-16 1994-04-20 エーザイ株式会社 吸収性の改良されたメナテトレノン含有組成物
EP0287646B1 (en) * 1986-10-23 1992-05-20 Arval S.P.A. Cosmetic preparations containing ubidecarenones
JPS63188623A (ja) * 1987-01-31 1988-08-04 Taisho Pharmaceut Co Ltd 吸収改善ユビデカレノン製剤
US5641504A (en) * 1988-06-09 1997-06-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolinoleate
US5189066A (en) * 1989-11-22 1993-02-23 The Procter & Gamble Company Pharmaceutical compositions of tebufelone
EP0448091B1 (en) * 1990-03-23 1998-08-05 The Green Cross Corporation Pharmaceutical composition containing slightly water-soluble drug
US5891466A (en) * 1990-08-13 1999-04-06 Yesair; David W. Mixed Liped-Bicarbonate colloidal particles for delivering drugs or calories
ATE121618T1 (de) * 1990-08-13 1995-05-15 David W Yesair Gemischte lipid-bicarbonat-kolloidale partikel zur abgabe von arzneien und kalorien.
US5571517A (en) * 1990-08-13 1996-11-05 Yesair; David W. Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories
MX9202350A (es) * 1991-05-20 1992-11-01 Alza Corp Composiciones de incrementador de penetracion a la piel que usan monolinoleato de glicerol.
US5281420A (en) * 1992-05-19 1994-01-25 The Procter & Gamble Company Solid dispersion compositions of tebufelone
JP3106820B2 (ja) * 1993-12-08 2000-11-06 アールティーエー・アソシエーツ有限会社 畜肉、魚肉およびこれらの加工品の鮮度保持剤並びに生産性改善剤
US5447729A (en) * 1994-04-07 1995-09-05 Pharmavene, Inc. Multilamellar drug delivery systems
EP0999838B1 (en) * 1997-07-29 2002-04-03 PHARMACIA & UPJOHN COMPANY Self-emulsifying formulation for lipophilic compounds
IT1304406B1 (it) 1998-10-21 2001-03-19 Danital Italia S R L Preparazione per la veicolazione di principi attivi basata su acidigrassi polinsaturi del gruppo omega 3.
US7179483B2 (en) 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
DE20122900U1 (de) 2001-07-12 2009-12-03 Aquanova Ag Ubichinon Konzentrat
JP2003055204A (ja) * 2001-08-21 2003-02-26 Sansho Iyaku Kk ユビデカレノン組成物及び同組成物を内容物とするカプセル
KR100533458B1 (ko) * 2002-07-20 2005-12-07 대화제약 주식회사 파클리탁셀의 가용화용 조성물 및 그의 제조 방법
JP4567945B2 (ja) * 2003-01-17 2010-10-27 太陽化学株式会社 ユビデカレノン製剤
CA2513276C (en) * 2003-01-17 2012-09-04 Taiyo Kagaku Co., Ltd. Compositions containing coenzyme q10
US20050260752A1 (en) * 2003-04-01 2005-11-24 Wilding Martin G Culture medium containing enhancers of oxidative phosphorylation
JP5258144B2 (ja) * 2004-12-21 2013-08-07 株式会社分子生理化学研究所 吸収性の改善された固形状のコエンザイムｑ１０経口製剤の製造方法
US8491888B2 (en) * 2006-05-05 2013-07-23 Softgel Formulators, Inc. Highly absorbable coenzyme Q10 composition and method of producing same
JP5181497B2 (ja) * 2007-03-05 2013-04-10 大正製薬株式会社 ユビデカレノン含有固形製剤用組成物
CN102892412B (zh) 2010-03-12 2015-09-30 博格制药有限责任公司 辅酶Q10(CoQ10)的静脉内制剂及其使用方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3317381A (en) * 1965-10-04 1967-05-02 Takeda Chemical Industries Ltd Method for treating peptic ulcer
US3426125A (en) * 1965-04-07 1969-02-04 Yukio Shigeta Method of treating diabetes mellitus
US3534137A (en) * 1965-09-30 1970-10-13 Takeda Chemical Industries Ltd Method of systemic therapy for severe early destructive periodontal disease
US3452144A (en) * 1966-03-26 1969-06-24 Takeda Chemical Industries Ltd Method for treatment of congestive heart failure with coenzyme qn
US3808330A (en) * 1972-07-13 1974-04-30 Eisai Co Ltd Method for treatment of hypertensive disease
JPS52136912A (en) * 1976-05-06 1977-11-16 Eisai Co Ltd Solia agent
DE2631282A1 (de) * 1976-07-12 1978-01-19 Kali Chemie Pharma Gmbh Verfahren zur erhoehung der loeslichkeit und des dispersitaetsgrades von schwerloeslichen arzneistoffen zum zwecke deren applikation in gelatinekapseln
DE2700433A1 (de) * 1977-01-07 1978-07-20 Kali Chemie Pharma Gmbh Arzneimittelzubereitungen mit verbesserten resorptionseigenschaften
DE2700371A1 (de) * 1977-01-07 1978-07-13 Kali Chemie Pharma Gmbh Verfahren zur herstellung fester und fluessiger loesungen von arzneistoffen zur oralen applikation
DE2700501A1 (de) * 1977-01-07 1978-07-20 Kali Chemie Pharma Gmbh Verfahren zur herstellung fester und fluessiger loesungen von arzneistoffen zur oralen applikation
JPS55147219A (en) * 1979-05-04 1980-11-17 Sanwa Kagaku Kenkyusho:Kk Solid ubidecarenone preparation
JPS55153717A (en) * 1979-05-18 1980-11-29 Tokai Kapuseru Kk Preparation of ubidecarenone soft capsule
JPS5612309A (en) * 1979-07-11 1981-02-06 Kyowa Hakko Kogyo Co Ltd Oral drug containing ubidecarenone

Also Published As

Publication number Publication date
EP0023349B1 (en) 1985-04-17
ES8106408A1 (es) 1981-07-01
EP0023349A2 (en) 1981-02-04
DE3070508D1 (en) 1985-05-23
JPS6410494B2 (es) 1989-02-22
JPS5618914A (en) 1981-02-23
EP0023349A3 (en) 1982-03-10
US4325942A (en) 1982-04-20
CA1159767A (en) 1984-01-03
ES493679A0 (es) 1981-07-01

Similar Documents

Publication Publication Date Title
PH16762A (en) Ubedecabenone compositions having enhanced absorption properties
GB2046283B (en) Soloxane composition
GB2057263B (en) Compositions containing methylsulphonylmethane
JPS565899A (en) Claning composition
JPS5634751A (en) Polycarbonateepolyolefin composition
JPS55129447A (en) Composition
GB2057422B (en) Glass compositions
JPS5682839A (en) Waterrabsorbable composition
JPS55152185A (en) Antiicorrosion agent composition
ZA801246B (en) Compounds and compositions
JPS564604A (en) Coinitiating agent composition
JPS56100347A (en) Laserrexpanded xxray absorption fineestructure
ZA805646B (en) Compounds and compositions
EG15103A (en) Oxytetrocycline compositions
IE800872L (en) Tickicidal compositions
JPS5691075A (en) Size composition
JPS55129229A (en) Indiumm1111oxine complex composition
GB2066237B (en) Glass compositions
JPS5622734A (en) Composition
JPS5649747A (en) Ureaaformaldehyde composition
JPS56135531A (en) Composition
JPS55118957A (en) Flameeproof composition
IL60600A0 (en) Pharmlaceutical compositions comprising certain azolyl-alkenol compounds
GB2058034B (en) Fluocculant composition
ZA803634B (en) Water-settable compositions